Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Chronic sinusitis is a frequent complication in cystic fibrosis. The aim of this study is to
determine whether Pulmozyme(dornase alfa) would maintain sinus health (compared to placebo)
in patients with cystic fibrosis who have recently undergone sinus surgery.